Let's talk medical research

Clinical research organizations sometimes create surveys and share general statistics about clinical trial participation. But every patient is different, and overarching stats don't tell the full story.

Today, nearly 60 million patients are needed for currently recruiting clinical trials. And in fact, 80% of trials will be delayed or closed due to difficulty finding patients to take part.

As medications become more targeted and sophisticated, the growing complexity of clinical trial protocols is making it more difficult than ever to find the perfect patients for your trials. That’s why a thoughtful and strategic patient recruitment strategy is key.

While approximately 15 to 20 percent of people 65+ have Mild Cognitive Impairment (MCI), it can be difficult to identify, and difficult to determine if it is related to Alzheimer’s disease. MCI does not always lead to dementia, but people with MCI are four times more likely to develop Alzheimer’s disease and other forms of dementia than those without it — so it’s important to treat this condition ...

Today, 70% of the 18 million adults in the U.S. experience moderate-to-severe symptoms. Nearly half of people with eczema report that they "often" or "always" feel frustrated by their disease. One-third report that they spend up to three hours per day treating their disease.

A few years ago, we wrote a blog series for ACRP in which we focused on patient centricity in clinical trial design, recruitment, and execution. Over the next few months, we’ll be taking a second look at those blog posts, sharing updated versions on our own blog. Here’s an update to the first in that series.

An estimated 5.8 million people in the United States have been diagnosed with Alzheimer's disease. As the millions of patients and caregivers around the country know too well, there is not a treatment option that slows or stops disease progression.

Living with a chronic illness or other condition can take up a significant piece of a patient's time. Though clinical trials can be beneficial to patients, recruitment efforts have to compete with many other products and services that can offer a patient support.

With patients waiting for new and better treatments and companies waiting for results, delays in clinical trials are far from ideal. And yet, here at Antidote, we receive calls and emails every day from researchers who are missing their trial’s deadlines because they’re having trouble finding patients to take part.

While there is no recommended diet for autoimmune hepatitis, diet considerations related to weight management and alcohol consumption may make an impact on both symptoms and disease progression. Following a healthy diet and talking with your doctor about alcohol consumption can help you avoid complications related to obesity, reduce weight gain from common steroid treatments, and avoid ...